Patent details

EP3589661 Title: ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

Basic Information

Publication number:
EP3589661
PCT Application Number:
US2018020154
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187120449
PCT Publication Number:
WO2018160654
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
French Title of Invention:
TRAITEMENT PAR ADJUVANTS DU CANCER DU SEIN HER2 POSITIF
German Title of Invention:
ADJUVANSBEHANDLUNG VON HER2-POSITIVEM BRUSTKREBS
SPC Number:

Dates

Filing date:
28/02/2018
Grant date:
01/11/2023
EP Publication Date:
08/01/2020
PCT Publication Date:
07/09/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/11/2023
EP B1 Publication Date:
01/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/02/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2023
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Name:
Genentech, Inc.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/01/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BENYUNES, Mark, C.
Address:
United States (US)

2

Name:
ROSS, Graham, Alexander
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201762466239 P
Priority Date:
02/03/2017
Priority Country:
United States (US)

2

Priority Number:
201762469317 P
Priority Date:
09/03/2017
Priority Country:
United States (US)

3

Priority Number:
201762486876 P
Priority Date:
18/04/2017
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/32; A61P 35/00; A61K 9/00; A61K 45/06; A61K 39/395; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202344
Publication date:
01/11/2023
Description:
Grant (B1)

2

Issue number:
202348
Publication date:
29/11/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
10/01/2024 Power Of Attorney 1
10/01/2024 Outgoing Correspondence 1